NPORT-EX 2 ea170308_nportexccp.htm

Constitution Capital Access Fund, LLC

Consolidated Schedule of Investments

December 31, 2023 (Unaudited)

 

 

Investments - 111.4%7  Sector  Investment Type  Acquisition
Date
  Shares   Fair Value 
Common Stocks - 0.0%                   
North America - 0.0%                   
Optinose, Inc.*  Health Care  Common Stock 

5/12/2023

   139,009   $179,322 
Total Common Stocks (Cost $263,908) - 0.0%                 179,322 
                    
Direct Investments - 49.3%1,2                   
Direct Credit - 0.2%                   
North America - 0.2%                   
COP Exterminators Acquisitions, Inc.3,9  Consumer Staples  Subordinated debt 

7/31/2023

        254,236 
($250,000 principal amount, 9% Cash 4% PIK, 1/28/2030)                   
PracticeTek Midco, LLC *9  Financial Technology  Subordinated debt 

8/30/2023

        1,048,658 
($1,000,000 principal amount, 14% PIK, 8/30/2030)                   
Total Direct Credit                 1,302,894 
                    
Direct Equity - 49.1%                   
Asia - Pacific - 3.2%                   
SLP Rainbow Co-Invest, L.P.*9  Consumer Staples  Limited partnership interest 

10/1/2022

        11,056,577 
SLP Redwood Co-Invest, L.P.*9  Communication Services  Limited partnership interest 

10/1/2022

        8,469,318 
Total Asia - Pacific                 19,525,895 
                    
Europe - 18.0%                   
Bach Co-investment L.P.1*9  Consumer Discretionary  Limited partnership interest 

10/1/2022

        33,924,117 
EQT VIII Co-Investment (D) SCSp*8,9  Health Care  Limited partnership interest 

10/1/2022

        18,444,830 
Kirk Beauty Co-Investment Limited Partnership*8,9  Consumer Discretionary  Limited partnership interest 

10/1/2022

        8,882,337 
Mayfair Olympic Holdco Limited*8,9  Utilities  Ordinary Shares 

10/1/2022

   1,243,556    11,171,702 
Neptune Co-Investment, L.P.*3,9  Energy  Limited partnership interest 

10/1/2022

        6,693,052 
SLP Jewel Co-Invest, L.P.*9  Consumer Discretionary  Limited partnership interest 

10/1/2022

        6,485,132 
SLP Mistral Co-Invest, L.P.*9  Financials  Limited partnership interest 

10/1/2022

        17,341,601 
SLP Zephyr Investors, L.P.*9  Communication Services  Limited partnership interest 

10/1/2022

        7,192,914 
Total Europe                 110,135,685 
                    
North America - 27.9%                   
ACP Canopy Co-Invest LLC*9  Health Care  Limited liability company interest 

11/1/2022

   20,082    25,185,773 
Ares EPIC Co-Invest Delaware Feeder, L.P.*3,9  Energy  Limited partnership interest 

10/1/2022

        4,463,850 
Ares EPIC Co-Invest II L.P.*3,9  Energy  Limited partnership interest 

10/1/2022

        11,128,654 
Carlyle Sabre Coinvestment, L.P.*9  Industrials  Limited partnership interest 

10/1/2022

        12,544,000 
CC AEC Co-Invest L.P.*9  Health Care  Limited partnership interest 

10/1/2022

   5,000    5,000,000 
Centeotl Co-Invest B, L.P.*9  Consumer Staples  Limited partnership interest 

5/15/2023

        5,000,000 
COP Exterminators Investment, LLC*9  Consumer Staples  Limited liability company interest 

7/28/2023

   8,035,714    9,000,000 
Ergotron Investments, LLC*9  Industrials  Limited liability company interest 

10/1/2022

   50,000    

7,242,866

 

 

See accompanying notes to the Consolidated Schedule of Investments.

 

 

 

Constitution Capital Access Fund, LLC

Consolidated Schedule of Investments

December 31, 2023 (Unaudited) (Continued)

 

 

Investments - 111.4%7  Sector  Investment Type  Acquisition
Date
  Shares   Fair Value 
Direct Investments (Continued)                   
Direct Equity (Continued)                   
North America (Continued)                   
Ishtar Co-Invest-B LP3,9  Consumer Staples  Limited partnership interest  11/4/2022        

30,316,689

 
LB Vacation Blocker LLC*7,9  Real Estate  Limited liability company interest 

4/10/2023

   2,793,296    

5,314,837

 
Oshun Co-Invest-B LP*3,9  Consumer Staples  Limited partnership interest 

11/4/2022

        

4,299,824

 
PT Co-Invest II, L.P.*9  Financial Technology  Limited partnership interest 

8/28/2023

        

10,000,000

 
RCP Monte Nido Co-Investment Fund, L.P.*9  Health Care  Limited partnership interest 

4/10/2023

        

5,748,000

 
SLP Blue Co-Invest, L.P.*9  Information Technology  Limited partnership interest  10/1/2022        

8,618,038

 
SLP West Holdings Co-Invest II, L.P.5  Communication Services  Limited partnership interest 

10/1/2022

        

7,168,449

 
TPG VII Renown Co-Invest II, L.P.*9  Consumer Discretionary  Limited partnership interest 

10/1/2022

        

3,741,560

 
WPP Fairway Aggregator B, L.P. - Class A*9  Consumer Staples  Preferred Units 

10/1/2022

   12,500    

14,133,994

 
WPP Fairway Aggregator B, L.P. - Class B*9  Consumer Staples  Common Units 

10/1/2022

   12,500    

1,854,446

 
Total North America                 

170,760,980

 
Total Direct Equity                 

300,422,560

 
Total Direct Investments (Cost $243,667,561) - 49.3%                  

301,725,454

 
                    
Investment Funds - 59.9%1,2                   
Asia - Pacific - 4.6%                   
BPEA Private Equity Fund VI, L.P.*3,9     Limited partnership interest 

10/1/2022

        

7,121,029

 
BPEA Private Equity Fund VII, SCSp*3,9     Limited partnership interest 

10/1/2022

        

21,122,110

 
Total Asia - Pacific                 

28,243,139

 
                    
Europe - 17.1%                   
CVC Capital Partners VI (D) S.L.P.*3,8,9     Limited partnership interest 

10/1/2022

        

11,184,702

 
CVC Capital Partners VII (A) L.P.*3,8,9     Limited partnership interest 

10/1/2022

        

21,876,767

 
EQT IX (No.1) EUR SCSp*3,8,9     Limited partnership interest 

10/1/2022

        

13,309,264

 
EQT VII (No.1) Limited Partnership*3,8,9     Limited partnership interest 

10/1/2022

        

8,871,417

 
EQT VIII (No.1) SCSp*3,8,9     Limited partnership interest 

10/1/2022

        

19,846,425

 
Sixth Cinven Fund (No. 2) Limited Partnership*3,8,9     Limited partnership interest 

10/1/2022

        

29,418,022

 
Total Europe                 

104,506,597

 
                    
North America - 38.2%                   
Ares Corporate Opportunities Fund V, L.P.*3,9     Limited partnership interest 

10/1/2022

        

14,522,590

 
Ares Corporate Opportunities Fund VI Parallel (TE), L.P.*3,9     Limited partnership interest 

10/1/2022

        

21,176,588

 
Ares Energy Opportunities Fund B, L.P.*3,9     Limited partnership interest 

10/1/2022

        

10,696,660

 
Bansk Fund I-B, L.P.3,9     Limited partnership interest 

9/13/2023

        3,617,980 
Carlyle International Energy Partners II S.C.Sp.3,9     Limited partnership interest 

10/1/2022

        

9,493,144

 

 

See accompanying notes to the Consolidated Schedule of Investments.

 

 

 

Constitution Capital Access Fund, LLC

Consolidated Schedule of Investments

December 31, 2023 (Unaudited) (Continued)

 

 

Investments - 111.4%7  Sector  Investment Type  Acquisition
Date
  Shares   Fair Value 
Investment Funds (Continued)                   
North America (Continued)                   
Carlyle Partners VI, L.P.*3,4,9     Limited partnership interest 

10/1/2022

        

3,594,200

 
Carlyle Partners VII, L.P.3,9     Limited partnership interest 

10/1/2022

        

10,784,003

 
Catterton Partners VII, L.P.*3,9     Limited partnership interest 

10/1/2022

        

13,354,921

 
Gridiron Capital (Parallel) Fund V, L.P.*3,9     Limited partnership interest 

11/27/2023

        

2,245,106

 
Insignia Capital Partners, L.P.*3,4,9     Limited partnership interest 

10/1/2022

        

17,446,670

 
Lightyear Fund III, L.P.3,4,9     Limited partnership interest 

10/1/2022

        

1,735,765

 
Nautic Partners VI-A, L.P.*3,9     Limited partnership interest 

10/1/2022

        

1,902,193

 
Revelstoke Capital Partners Fund III, L.P.*3,9     Limited partnership interest 

8/22/2023

        

2,508,076

 
Riverstone Non-ECI Partners, L.P.3,9     Limited partnership interest 

10/1/2022

        

4,489,753

 
Riverstone Global Energy and Power VI, L.P.3,9     Limited partnership interest 

10/1/2022

        11,013,184 
Silver Lake Partners IV, L.P.3,4,9     Limited partnership interest 

10/1/2022

        

16,524,248

 
Silver Lake Partners V, L.P.3,4,9     Limited partnership interest 

10/1/2022

        

18,363,631

 
SK Capital Partners III, L.P.*3,9     Limited partnership interest 

10/1/2022

        

18,112,303

 
SL SPV-2, L.P.9     Limited partnership interest 

10/1/2022

        

5,294,324

 
SunTx Capital Partners II, L.P.*9     Limited partnership interest 

10/1/2022

        

10,989,638

 
TPG HealthCare Partners, L.P.3,9     Limited partnership interest 

10/1/2022

        

5,794,734

 
TPG Partners VI, L.P.3,9     Limited partnership interest 

10/1/2022

        

1,879,723

 
TPG Partners VIII, L.P.3,9     Limited partnership interest 

10/1/2022

        

20,256,368

 
WestView Capital Partners III, L.P.*3,9     Limited partnership interest 

10/1/2022

        

5,995,272

 
Wind Point Partners VII-B, L.P.*3,9     Limited partnership interest 

10/1/2022

        

2,103,220

 
Total North America                 

233,894,294

 
Total Investment Funds (Cost $396,130,453) - 59.9%                  

366,644,030

 
                    
Short-Term Investments - 2.2%                   
North America - 2.2%                   
Fidelity Institutional Government Portfolio - Class I, 5.17%6            12,936,151    

12,936,151

 
Total Short-Term Investments (Cost $12,936,151) - 2.2%                  

12,936,151

 
                    
Total Investments (Cost $652,998,073) - 111.4%                

681,484,957

 
Net Other Assets (Liabilites) - (11.4%)                 

(69,648,700

)
Total Net Assets - 100.0%                $

611,836,257

 

 
* Investment is non-income producing.
1 Direct Investments and Investment Funds are generally issued in private placement transactions and as such are generally restricted as to resale. Each investment may have been acquired on various dates and for different amounts. The acquisition date is shown in the Consolidated Schedule of Investments. Total fair value of restricted investments as of December 31, 2023 was $668,369,484, or 109.2% of net assets. As of December 31, 2023, the aggregate cost of each investment restricted to resale was $244,644, $1,018,658, $11,121,157, $8,588,727, $21,223,189, $16,747,016, $5,456,837, $7,914,290, $9,812,065, $5,870,914, $14,149,547, $7,816,775, $20,081,967, $5,922,469, $9,589,902, $9,874,488, $5,003,501, $5,160,290, $9,000,000, $5,000,000, $6,811,827, $5,000,000, $3,424,171, $10,000,000, $6,011,250, $8,727,785, $6,504,292, $5,091,800, $12,500,000, $0, $12,100,977, $20,925,981, $14,002,964, $20,514,176, $12,566,206, $8,786,996, $21,073,967, $26,003,108, $15,499,395, $18,987,453, $11,488,344, $3,280,310, $12,525,949, $5,012,160, $10,162,325, $16,790,085, $2,187,710, $28,550,585, $2,042,794, $5,232,551, $2,560,356, $5,511,194, $13,577,135, $15,745,415, $18,934,460, $21,057,194, $5,606,424, $6,655,799, $5,573,053, $3,024,112, $18,889,474, $9,515,956 and $1,745,845 respectively, totaling $639,798,014.
2 Direct Investments and Investment Funds do not allow redemptions or withdrawals except at discretion of their general partner, manager, or adviser.
3 Investment has been committed to but has not been fully funded by the Fund.
4 All or a portion of this security is held through a consolidated Subsidiary, CC PMF Splitter Partnership.
5 All or a portion of this security is held through a consolidated Subsidiary, CC PMF Blocker, LLC.
6 The rate is the annualized seven-day yield as of December 31, 2023.
7 Investments are held through CC PMF Holdings, LLC, a consolidated Subsidiary, unless otherwise denoted.
8 Foreign security denominated in U.S. Dollars.
9 Level 3 security in accordance with fair value hierarchy.

 

See accompanying notes to the Consolidated Schedule of Investments.

 

 

 

Constitution Capital Access Fund, LLC

Notes To Consolidated Schedule of Investments

December 31, 2023 (Unaudited)

 

Note 1 - Valuation of Investments

In December 2020, the SEC adopted a new rule providing a framework for fund valuation practices (“Rule 2a-5”). Rule 2a-5 establishes requirements for determining fair value in good faith for purposes of the Investment Company Act. Rule 2a-5 permits fund boards to designate certain parties to perform fair value determinations, subject to board oversight and certain other conditions. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the Investment Company Act and the threshold for determining whether a fund must fair value a security. Pursuant to the requirements of Rule 2a-5, the Board designated the Adviser as its valuation designee to perform fair value determinations and approved valuation procedures for the Fund.

 

The Fund invests, under normal circumstances, in a broad portfolio of Private Assets and values them in accordance with the provisions of ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). To determine the estimated value of the Fund’s interests or shares in Investment Funds, the Adviser considers, among other things, information provided by the Investment Funds, including quarterly unaudited financial statements. The Adviser will review the appropriateness of the valuation based on any new information or changes in assumptions regarding the security, reliable public information, actual trade prices or other information that becomes available subsequent to the most recent quarterly valuation determination. If changes are required, the Adviser will make a market adjustment and provide an updated valuation to UMB Fund Services, Inc. (the “Administrator”) to revise it accordingly.

 

The Fund’s Direct Investments are generally not publicly traded, and thus, market quotations are not available to be used for valuation purposes. Therefore, the Adviser is required to value these Direct Investments at estimated fair values, using present value and other subjective valuation techniques. These may include references to market multiples, valuations for comparable companies, public market or private transactions, subsequent developments concerning the companies to which the securities relate, results of operations, financial condition, cash flows, and projections of such companies provided to the Adviser and such other factors as the Adviser may deem relevant. Depending on the circumstances, company multiples will not always be comparable due to the size of the related companies or associated transactions being used as comparable data in valuation. If the Adviser determines that the estimated fair value does not represent fair value, a fair value determination is made by the Adviser in accordance with the Adviser’s Valuation Policy.

 

Securities traded on one or more of the U.S. national securities exchanges, the Nasdaq Stock Market or any foreign stock exchange will be valued based on their respective market price adjusted for potential restrictions on the transfer or sale of such securities.

 

Note 2 – Fair Value Measurements

In general, fair value represents a good faith approximation of the current value of an asset and will be used when there is no public market or possibly no market at all for the asset. The fair values of one or more assets may not be the prices at which those assets are ultimately sold, and the differences may be significant. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price) and establishes a fair value hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are those that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Adviser. Unobservable inputs reflect the Adviser’s assumption about the inputs market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels based on the inputs as follows:

 

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. The types of financial instruments included in Level 1 are listed unrestricted securities, equities and listed derivatives, if any, listed in active markets.

 

Level 2 – Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly in active markets as of the reporting date, and fair value that is determined using models or other valuation methodologies. Financial instruments in this category generally include corporate bonds and loans, less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities, certain over-the-counter derivatives and redeemable investments in alternative investment funds, if any, where the fair value is based on observable inputs. A significant adjustment to a Level 2 input could result in the Level 2 measurement becoming a Level 3 measurement.

 

Level 3 – Inputs that are unobservable for the asset or liability and that include situations where there is little, if any, market activity for the asset or liability. The inputs into the determination of fair value are based upon the best information in the circumstances and may require significant management judgment or estimation. Financial instruments in this category generally include equity and debt positions in private companies, and nonredeemable investments in alternative investment funds, non-investment grade residual interests in securitizations, collateralized loan obligations, and certain over-the-counter derivatives, if any, where the fair value is based on unobservable inputs.

 

 

 

Constitution Capital Access Fund, LLC

Notes To Consolidated Schedule of Investments

December 31, 2023 (Unaudited) (Continued)

 

ASC 820 permits a reporting entity to measure the fair value of an asset that does not have a readily determinable fair value based on the reported net asset value (“NAV”) per share, or its equivalent, without further adjustment as a practical expedient for its fair value. Accordingly, the Fund may utilize the NAV per share as reported by certain Private Assets as of a measurement date as a practical expedient for its fair value.

 

Due to the inherent uncertainty of estimates, fair value determinations based on estimates may materially differ from the values that would have been used had a ready market for the securities existed.

 

The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.

 

The following table is a summary of information about the levels within the fair value hierarchy at which the Fund’s investments are measured as of December 31, 2023:

 

   Level 1   Level 2   Level 3   Total 
Investments                
Common Stocks  $179,322   $-   $-   $179,322 
Direct Investments   -    7,168,449    294,557,005    301,725,454 
Investment Funds   -    -    366,644,030    366,644,030 
Short-Term Investments   12,936,151    -    -    12,936,151 
Total Investments  $13,115,473   $7,168,449   $661,201,035   $681,484,957